MDGL Latest Press Releases, Madrigal Pharmac Corporate News

Open account

Releases

212.04

-4.60%

-10.22

All
Financials
Insiders

4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 10,2024 20:55
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 10,2024 20:51
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 05,2024 20:51
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 05,2024 20:51
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 03,2024 20:48
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 03,2024 20:45
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 03,2024 20:42
144 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 03,2024 16:24
144 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 03,2024 16:24
8-K | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 02,2024 16:32
144 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 01,2024 16:35
144 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 01,2024 16:25
144 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Apr 01,2024 16:23
SC 13D/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Mar 25,2024 16:29
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Mar 25,2024 16:22
3 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Mar 21,2024 16:33
8-K | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Mar 20,2024 16:12
424B5 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Mar 20,2024 16:08
424B5 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Mar 18,2024 16:09
8-K | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Mar 15,2024 06:16
8-K | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 28,2024 07:11
8-K | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 28,2024 07:02
10-K | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 28,2024 06:34
UPLOAD | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 23,2024 10:06
UPLOAD | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 23,2024 10:05
CORRESP | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 23,2024 10:05
CORRESP | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 23,2024 10:05
CORRESP | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 23,2024 10:05
UPLOAD | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 23,2024 10:05
SC 13G/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 14,2024 17:11
SC 13G/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 14,2024 14:51
SC 13G/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 14,2024 09:22
SC 13G/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 13,2024 18:36
SC 13G/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Feb 13,2024 18:10
SC 13G/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 29,2024 17:27
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 25,2024 18:05
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 25,2024 17:55
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 25,2024 17:52
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 25,2024 15:30
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 25,2024 15:25
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 25,2024 15:25
SC 13G/A | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 22,2024 11:14
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 18,2024 13:53
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 18,2024 13:48
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 18,2024 13:48
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 18,2024 13:46
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 18,2024 13:40
8-K | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Jan 08,2024 13:46
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Dec 19,2023 09:15
4 | MADRIGAL PHARMACEUTICALS, INC.(0001157601)
Dec 14,2023 18:12

Webull provides the latest Madrigal Pharmac (MDGL) stock and general news. This information may help you make smarter investment decisions.

About MDGL

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.